Compare eBay Inc (EBAY) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Natera Inc. Common Stock — how do they compare? eBay Inc trades at $118.09 (market cap $52.01B), while Natera Inc. Common Stock trades at $393.93 (market cap $57.03B). The key difference: eBay Inc and Natera Inc. Common Stock are close in size by market cap, and eBay Inc pays a 1.06% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Natera Inc. Common Stock for 0 Days on average.
| EBAY | NTRA | |
|---|---|---|
Market Cap | $52.01B | $57.03B |
Volume | 3,194,736 | 1,131,157 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $425.64 |
52-Week Low | $79.41 | $179.42 |
Typical Hold Time | 134 Days | 0 Days |
Enterprise Value | $55.83B | $56.18B |
Dividend Yield | 1.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $116.41, up 1.54% today, near its consensus price target of $117.89. The stock shows strong technical momentum with bullish moving averages and recent earnings beats. Revenue grew to $11.10B in 2025, with robust profitability margins including a net income margin of 18.57%. Recent news highlights strategic focus on collectibles and live commerce, while facing scrutiny over banned product listings.
Outlook remains cautiously optimistic with analyst consensus leaning buy (49% buy ratings). Key opportunities include projected revenue growth to $12.0B in 2026 and expanding margins. Risks involve competitive pressures from Amazon's multi-platform tools, insider selling by executives, and regulatory challenges as seen in recent gender-test kit probe.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
